Signaling Pathways - Smoothened - eIF4E/eIF3G interaction - Farnesyltransferase - Vitamin D receptors (VDRs)
清除全部
- B3696 4EGI-12 CitationTarget: eIF4E/eIF3G interactionSummary: 竞争性的eIF4E/eIF4G相互作用抑制剂。
- B2140 Calcifediol中文名: 骨化二醇Target: Vitamin D receptors (VDRs)Summary: 维生素D3的主要循环形式
- B2091 Doxercalciferol1 Citation中文名: 度骨化醇Target: Vitamin D receptors (VDRs)Summary: 维生素D受体激活剂
- B2266 LDE225 (NVP-LDE225,Erismodegib)1 Citation中文名: 索尼德吉Target: SmoothenedSummary: Smoothened抑制剂
- B3283 PF-04449913中文名: 格拉吉布Target: SmoothenedSummary: Smoothened拮抗剂
- A8463 Lithocholic Acid中文名: 石胆酸Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)Summary: 维生素D受体PXR和FXR的激活剂
- A8340 Cyclopamine1 Citation中文名: 环巴胺Target: SmoothenedSummary: Hedgehog (Hh)信号抑制剂
- A4443 Gliotoxin1 CitationTarget: 20S proteasomal chymotrypsin|Geranylgeranyltransferase I|FarnesyltransferaseSummary: 20S蛋白酶体抑制剂
- A3543 LDE225 DiphosphateTarget: SmoothenedSummary: Smo拮抗剂
- A3396 ErcalcitriolTarget: Vitamin D receptors (VDRs)Summary: 维生素D2的活性代谢物